A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Kent C. Shih; Sajeel Chowdhary; Paul Rosenblatt; Alva B. Weir; Gregg C. Shepard; Jeffrey T. Williams; Mythili Shastry; Howard A. Burris; John D. Hainsworth

doi:10.1007/S11060-016-2172-3

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Kent C. Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B. Weir, Gregg C. Shepard, Jeffrey T. Williams, Mythili Shastry, Howard A. Burris, John D. Hainsworth

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of neuro-oncology
Volume	129
DOIs	https://doi.org/10.1007/S11060-016-2172-3
State	Published - Jun 16 2016
Externally published	Yes

Disciplines

Medicine and Health Sciences
Surgery

Access to Document

10.1007/S11060-016-2172-3License: Unspecified

Cite this

@article{504df01006f940818921bc58479e4a23,

title = "A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma",

author = "Shih, \{Kent C.\} and Sajeel Chowdhary and Paul Rosenblatt and Weir, \{Alva B.\} and Shepard, \{Gregg C.\} and Williams, \{Jeffrey T.\} and Mythili Shastry and Burris, \{Howard A.\} and Hainsworth, \{John D.\}",

note = "Meningiomas that progress after standard therapies are challenging with limited effective chemotherapy options. This phase II trial evaluated the efficacy of everolimus plus bevacizumab in patients with recurrent, progressive meningioma after treatment with surgical resection and local radiotherapy when appropriate.",

year = "2016",

month = jun,

day = "16",

doi = "10.1007/S11060-016-2172-3",

language = "American English",

volume = "129",

journal = "Journal of neuro-oncology",

}

TY - JOUR

T1 - A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

AU - Shih, Kent C.

AU - Chowdhary, Sajeel

AU - Rosenblatt, Paul

AU - Weir, Alva B.

AU - Shepard, Gregg C.

AU - Williams, Jeffrey T.

AU - Shastry, Mythili

AU - Burris, Howard A.

AU - Hainsworth, John D.

N1 - Meningiomas that progress after standard therapies are challenging with limited effective chemotherapy options. This phase II trial evaluated the efficacy of everolimus plus bevacizumab in patients with recurrent, progressive meningioma after treatment with surgical resection and local radiotherapy when appropriate.

PY - 2016/6/16

Y1 - 2016/6/16

UR - http://europepmc.org/abstract/MED/27311730

U2 - 10.1007/S11060-016-2172-3

DO - 10.1007/S11060-016-2172-3

M3 - Article

VL - 129

JO - Journal of neuro-oncology

JF - Journal of neuro-oncology

ER -

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Disciplines

Access to Document

Other files and links

Cite this